Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -0.93% | -4.50% | +20.45% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.45% | 134M | |
+50.19% | 56.87B | |
+37.15% | 39.72B | |
-5.83% | 39.27B | |
-6.90% | 28.73B | |
+13.24% | 26.21B | |
-15.57% | 19.79B | |
+32.15% | 12.28B | |
+27.87% | 12.23B | |
+0.60% | 12.12B |
- Stock Market
- Equities
- CRVS Stock
- News Corvus Pharmaceuticals, Inc.
- Oppenheimer Adjusts Corvus Pharmaceuticals Price Target to $8 From $7, Maintains Outperform Rating